文献速递主动脉疾病

胸主动脉腔内修复术中脊髓麻醉的应用

Use of Spinal Anesthesia during Thoracic Endovascular Aortic Repair.
PubMed 文献 · Ann Vasc Surg · 2023-10-05

单中心回顾性研究纳入2001至2019年333例胸主动脉腔内移植物置入患者,比较脊髓麻醉与全身麻醉的结局。脊髓麻醉组30天死亡率0% vs 全身麻醉组5.6%(P=0.01),住院时间4.29天 vs 9.70天(P<0.001)。脊髓麻醉联合脑脊液引流组围术期并发症发生率0% vs 全身麻醉联合脑脊液引流组33.3%(P=0.01)。

要点

  • 脊髓麻醉组住院时间4.29天 vs 全身麻醉组9.70天(P<0.001)
  • 脊髓麻醉组30天死亡率0% vs 全身麻醉组5.6%(P=0.01)
  • 脊髓麻醉联合脑脊液引流组围术期并发症0% vs 全身麻醉联合脑脊液引流组33.3%(P=0.01)

核心结论

  • 在经选择的高危患者中,脊髓麻醉与全身麻醉相比与降低的30天死亡率、神经并发症和住院时间相关。
  • 脊髓引流与脊髓麻醉联合使用相比脊髓引流与全身麻醉联合使用获得满意结果。

研究设计与样本

  • 单中心回顾性综述,纳入2001至2019年接受胸主动脉腔内移植物置入的患者333例。
  • 患者按麻醉类型分层:全身麻醉104例?原文未写明全身麻醉组例数?原文写180例接受全身麻醉,104例接受脊髓麻醉,30例接受全身麻醉加脑脊液引流,19例接受脊髓麻醉加脑脊液引流。

主要发现

  • 脊髓麻醉组平均年龄73.4岁 vs 全身麻醉组64.7岁(P<0.001)。
  • 脊髓麻醉组住院时间4.29天 vs 全身麻醉组9.70天(P<0.001)。
  • 脊髓麻醉组30天死亡率0% vs 全身麻醉组5.6%(P=0.01)。
  • 脊髓麻醉组再次干预19.2% vs 全身麻醉组26.8%(P=0.02),重返手术室6.8% vs 12.7%(P=0.02)。
  • 脊髓麻醉加脑脊液引流组围术期并发症0% vs 全身麻醉加脑脊液引流组33.3%(P=0.01)。

关键数值与推荐

  • 脊髓麻醉在高危全身麻醉患者中更受偏好:年龄>75岁52.9% vs 33.3%(P<0.001);肾脏合并症20.6% vs 10.6%(P=0.03);当前吸烟26.7% vs 9.6%(P<0.001)。
  • 多因素logistic回归分析显示年龄>75岁(P=0.002)、术中并发症(P<0.001)和围术期并发症(P=0.02)与胸主动脉腔内移植物置入后死亡率增加相关。
  • 脊髓麻醉组脊髓缺血发生率1.0% vs 全身麻醉组2.2%(P=0.44)。
  • 全身麻醉加脑脊液引流组与脊髓麻醉加脑脊液引流组在术中并发症、神经并发症或30天死亡率风险方面无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to assess outcomes after spinal anesthesia (SA) versus general anesthesia (GA) in patients undergoing thoracic endograft placement and to evaluate the adjunctive use of cerebrospinal fluid drainage (CSFD) placement. METHODS: A single-center retrospective review of patients that underwent thoracic endograft placement from 2001 to 2019 was performed. Patients were stratified based on the type of anesthesia they received: GA, SA or epidural, GA with CSFD, and SA with CSFD. Primary outcomes included 30-day mortality and length of stay (LOS). Baseline characteristics were analyzed with Student's t-test and Pearson's chi-squared test. Multivariate logistic regression analysis was performed to identify risk factors for 30-day mortality and longer LOS. RESULTS: A total of 333 patients underwent thoracic endograft placement; 104 patients received SA, 180 patients received GA, 30 patients received GA and CSFD, and 19 patients received SA and CSFD. Of the total patients, 16.2% underwent thoracic endograft placement for type B aortic dissection, 3.3% for type A aortic dissection, and 12.3% for penetrating ulcer. The mean age of the study population was 68.7 years old. Patients undergoing SA were older with a mean age of 73.4 years versus 64.7 years for patients undergoing GA (P < 0.001). Spinal anesthesia (SA) was preferred in patients at high risk for GA (>75 years old: 52.9% vs. 33.3%, P < 0.001; renal comorbidities: 20.6% vs. 10.6%, P = 0.03, and current smokers: 26.7% vs. 9.6%, P < 0.001). Length of stay (LOS) was decreased in the SA group (4.29 days vs. 9.70 days, P < 0.001). There was a lower incidence of spinal cord ischemia in the SA group (1.0% vs. 2.2%, P = 0.44), as well as significantly decreased 30-day mortality (0% vs. 5.6%, P = 0.01), reintervention (19.2% vs. 26.8%, P = 0.02), and return to the operating room (6.8% vs. 12.7%, P = 0.02). Of the 19 patients that had SA + CSFD, there were no signs and symptoms of spinal cord ischemia and decreased incidence of perioperative complications (0% vs. 33.3%, P = 0.01). There was no difference in the risk for intraoperative complications, neurologic complications, or 30-day mortality between GA + CSFD patients versus SA + CSFD patients. Age >75 (P = 0.002), intraoperative complications (P < 0.001), and perioperative complications (P = 0.02) were associated with increased mortality after thoracic endograft placement per multivariate logistic regression analysis. CONCLUSIONS: Spinal anesthesia (SA) in select high-risk patients was associated with reduced 30-day mortality, neurologic complications, and LOS compared to GA. The concurrent use of spinal drainage and SA had satisfactory results compared to spinal drainage and GA.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Gross BD, Zhu J, Rao A, et al. Use of Spinal Anesthesia during Thoracic Endovascular Aortic Repair. Ann Vasc Surg. 2023. PMID: 37802146. doi:10.1016/j.avsg.2023.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。